{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:45:33Z","timestamp":1778125533023,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2081,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/labinvest.2017.20","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T13:41:15Z","timestamp":1488807675000},"page":"591-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Increased expression of latent TGF-\u03b2-binding protein 4 affects the fibrotic process in scleroderma by TGF-\u03b2\/SMAD signaling"],"prefix":"10.1016","volume":"97","author":[{"given":"Jiaying","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhen","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangguang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weilin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiucun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2017.20_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/abd1806-4841.20152890","article-title":"Localized scleroderma: clinical spectrum and therapeutic update","volume":"90","author":"Careta","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1038\/labinvest.2017.20_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","article-title":"Transforming growth factor beta as a therapeutic target in systemic sclerosis","volume":"5","author":"Varga","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1038\/labinvest.2017.20_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5114\/pdia.2015.48044","article-title":"Evaluation of serum concentrations of the selected cytokines in patients with localized scleroderma","volume":"33","author":"Budzynska-Wlodarczyk","year":"2016","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1038\/labinvest.2017.20_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MCG.0000000000000334","article-title":"Gastrointestinal manifestations, malnutrition, and role of enteral and parenteral nutrition in patients with scleroderma","volume":"49","author":"Bharadwaj","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1038\/labinvest.2017.20_bib5","first-page":"3786","article-title":"IL-1R1\/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice","volume":"117","author":"Gasse","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2017.20_bib6","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s10753-012-9491-0","article-title":"Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats","volume":"35","author":"Akgedik","year":"2012","journal-title":"Inflammation"},{"key":"10.1038\/labinvest.2017.20_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jcb.23385","article-title":"LTBPs, more than just an escort service","volume":"113","author":"Todorovic","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1038\/labinvest.2017.20_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.autrev.2006.06.001","article-title":"Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis","volume":"5","author":"Verrecchia","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1038\/labinvest.2017.20_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","article-title":"Role of transforming growth factor-beta superfamily signaling pathways in human disease","volume":"1782","author":"Gordon","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/labinvest.2017.20_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jcp.22082","article-title":"Independent regulation of short and long forms of latent TGF-beta binding protein (LTBP)-4 in cultured fibroblasts and human tissues","volume":"223","author":"Kantola","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1038\/labinvest.2017.20_bib11","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1002\/jcp.24094","article-title":"Specificity of latent TGF-beta binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin","volume":"227","author":"Zilberberg","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1038\/labinvest.2017.20_bib12","doi-asserted-by":"crossref","first-page":"e65614","DOI":"10.1371\/journal.pone.0065614","article-title":"Latent transforming growth factor beta-binding protein 4 is downregulated in esophageal cancer via promoter methylation","volume":"8","author":"Bultmann","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1038\/labinvest.2017.20_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13402-011-0023-y","article-title":"Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas","volume":"34","author":"Kretschmer","year":"2011","journal-title":"Cell Oncol"},{"key":"10.1038\/labinvest.2017.20_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ijc.25698","article-title":"The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome","volume":"129","author":"Chan","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1038\/labinvest.2017.20_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2012.06.005","article-title":"LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma","volume":"325","author":"Chen","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1038\/labinvest.2017.20_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1600-0463.2007.apm_453.x","article-title":"Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitroin vivo","volume":"115","author":"Mauel","year":"2007","journal-title":"APMIS"},{"key":"10.1038\/labinvest.2017.20_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10555-015-9556-2","article-title":"Association of chromosome 19 to lung cancer genotypes and phenotypes","volume":"34","author":"Wang","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"10.1038\/labinvest.2017.20_bib18","first-page":"403","article-title":"Modeling autosomal recessive cutis laxa type 1C in mice reveals distinct functions for Ltbp-4 isoforms","volume":"8","author":"Bultmann-Mellin","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1038\/labinvest.2017.20_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2353\/ajpath.2009.080620","article-title":"Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin","volume":"174","author":"Zhou","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2017.20_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.1780370313","article-title":"Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis","volume":"37","author":"Sato","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2017.20_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1472-6882-14-224","article-title":"Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"10.1038\/labinvest.2017.20_bib22","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.27498","article-title":"Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis","volume":"62","author":"Yoshizaki","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2017.20_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1038\/labinvest.2017.20_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/039463201102400305","article-title":"Attenuation of expression of extracellular matrix genes with siRNAs to Sparc and Ctgf in skin fibroblasts of CTGF transgenic mice","volume":"24","author":"Wang","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1038\/labinvest.2017.20_bib25","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar2973","article-title":"Attenuation of fibrosis in vitroin vivo with SPARC siRNA","volume":"12","author":"Wang","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/labinvest.2017.20_bib26","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.4049\/jimmunol.1402362","article-title":"EBI3 downregulation contributes to type I collagen overexpression in scleroderma skin","volume":"195","author":"Kudo","year":"2015","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2017.20_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1346-8138.2009.00738.x","article-title":"Mechanisms of skin fibrosis in systemic sclerosis","volume":"37","author":"Jinnin","year":"2010","journal-title":"J Dermatol"},{"key":"10.1038\/labinvest.2017.20_bib28","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.yexcr.2008.05.010","article-title":"Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion","volume":"314","author":"Kantola","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1038\/labinvest.2017.20_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10875-014-0037-0","article-title":"Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels","volume":"34","author":"Vettori","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1038\/labinvest.2017.20_bib30","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1038\/srep05336","article-title":"Time-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosis","volume":"4","author":"Gazdhar","year":"2014","journal-title":"Sci Rep"},{"key":"10.1038\/labinvest.2017.20_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/labinvest.2017.20_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13075-015-0754-7","article-title":"Macitentan inhibits the transforming growth factor-beta profibrotic action, blocking the signaling mediated by the ETR\/TbetaRI complex in systemic sclerosis dermal fibroblasts","volume":"17","author":"Cipriani","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/labinvest.2017.20_bib33","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3899\/jrheum.150088","article-title":"The endothelial-mesenchymal transition in systemic sclerosis is induced by endothelin-1 and transforming growth factor-beta and may be blocked by macitentan, a dual endothelin-1 receptor antagonist","volume":"42","author":"Cipriani","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1038\/labinvest.2017.20_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jcp.20972","article-title":"Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression","volume":"211","author":"Cutroneo","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1038\/labinvest.2017.20_bib35","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.20225","article-title":"An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma","volume":"50","author":"Pannu","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2017.20_bib36","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1002\/art.22063","article-title":"Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: a model of scleroderma","volume":"54","author":"Pannu","year":"2006","journal-title":"Arthritis Rheum"}],"updated-by":[{"DOI":"10.1038\/labinvest.2017.43","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000}}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201720","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722007243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722007243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/labinvest.2017.20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T01:10:12Z","timestamp":1750036212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722007243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0023683722007243"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2017.20","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased expression of latent TGF-\u03b2-binding protein 4 affects the fibrotic process in scleroderma by TGF-\u03b2\/SMAD signaling","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2017.20","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2017.43","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.27","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}